Skip to content

European Study to Establish Biomarkers of Human Ageing

European Study to Establish Biomarkers of Human Ageing - MARK-AGE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00007713
Enrollment
3300
Registered
2015-03-18
Start date
2008-11-03
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging

Interventions

Group 1: (A) Randomly recruited age-stratified individuals from the general population covering the age range 35-74 years
(B) subjects born from a long-living parent belonging to a family with long living sibling(s) already recruited in the framework of the GEHA project. For genetic reasons such individuals (“GEHA offspr

Sponsors

European Commission Directorate-General for Research and Innovation Health Research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 74 Years

Inclusion criteria

Inclusion criteria: Randomly recruited age-stratified individuals from the general population (both sexes) aged 35-74, who signed informed consent. Son or daughter of GEHA 90+ siblings, and their spouses; probands must be aged 55-74 who signed informed consent. Subjects affected by Down syndrome (DS), WS (Werner syndrome) and Cockayne syndrome (CS) that signed informed consent through their responsible family member or caregivers.

Exclusion criteria

Exclusion criteria: Subjects with any of the following characteristics were excluded from the study: [1] self reported seropositivity for HIV, HBV (except seropositivity by vaccination) and HCV; [2] seropositivity for HBV or HCV assessed after blood collection; [3] current cancer treatment or administration of glucocorticoids; [4] less than 50% of lifetime spent in country of residence; [5] inability to give informed consent. N.B. In the case of acute illness within the 7 days preceding the scheduled appointment.

Design outcomes

Primary

MeasureTime frame
MARK-AGE aims the identification of powerful biomarkers of human ageing across a range of physiological systems

Secondary

MeasureTime frame
Recruitment of probands enables, in the first place, a cross-sectional approach to develop biomarkers of ageing. However, within the lifetime of the project (60 months), a limited random sample of probands will be re-tested in order to establish a longitudinal component within the study.

Countries

Austria, Belgium, Finland, Germany, Greece, Italy, Netherlands, Poland

Contacts

Public ContactAlexander Buerkle

Universität Konstanz

alexander.buerkle@uni-konstanz.de+497531884035

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026